Cas no 16357-75-8 (5-Pyrimidinecarbonitrile,4-hydrazinyl-)
5-Pyrimidinecarbonitrile,4-hydrazinyl- Chemical and Physical Properties
Names and Identifiers
-
- 5-Pyrimidinecarbonitrile,4-hydrazinyl-
- 5-Pyrimidinecarbonitrile, 4-hydrazino- (8CI)
- 4-Hydrazino-5-amino-6-methylpyrimidin
- 4-Hydrazino-5-cyan-pyrimidin
- 4-hydrazino-6-methyl-pyrimidin-5-ylamine
- 4-hydrazino-pyrimidine-5-carbonitrile
- MG 1
- 4-Hydrazinylpyrimidine-5-carbonitrile
- AKOS006336100
- 16357-75-8
- SB57052
- 4-hydrazinopyrimidine-5-carbonitrile
- 5-Pyrimidinecarbonitrile,4-hydrazino-(8ci)
-
- Inchi: 1S/C5H5N5/c6-1-4-2-8-3-9-5(4)10-7/h2-3H,7H2,(H,8,9,10)
- InChI Key: CDCUXECTYKUWCZ-UHFFFAOYSA-N
- SMILES: N(C1C(C#N)=CN=CN=1)N
Computed Properties
- Exact Mass: 135.05400
- Monoisotopic Mass: 135.054
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 10
- Rotatable Bond Count: 0
- Complexity: 147
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 87.6A^2
- XLogP3: 0
Experimental Properties
- PSA: 87.62000
- LogP: 0.40718
5-Pyrimidinecarbonitrile,4-hydrazinyl- Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Pyrimidinecarbonitrile,4-hydrazinyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A089000337-1g |
4-Hydrazinylpyrimidine-5-carbonitrile |
16357-75-8 | 97% | 1g |
$634.51 | 2022-04-02 | |
| Chemenu | CM507413-1g |
4-Hydrazinylpyrimidine-5-carbonitrile |
16357-75-8 | 97% | 1g |
$575 | 2023-02-02 |
5-Pyrimidinecarbonitrile,4-hydrazinyl- Related Literature
-
Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
Additional information on 5-Pyrimidinecarbonitrile,4-hydrazinyl-
5-Pyrimidinecarbonitrile,4-hydrazinyl-: A Comprehensive Overview
5-Pyrimidinecarbonitrile,4-hydrazinyl- is a unique compound that has garnered significant attention in the field of biomedical research. This compound belongs to the family of pyrimidine derivatives, which are known for their diverse applications in drug discovery and chemical synthesis. Its structure features a pyrimidine ring substituted with a cyano group at position 5 and a hydrazine moiety at position 4, making it a fascinating subject for both academic and industrial investigations.
The compound's unique combination of functional groups positions it as a potential candidate for various biomedical applications. Its pyrimidine core provides a rigid and aromatic framework, while the cyano group introduces electron-withdrawing properties, enhancing its reactivity in chemical transformations. The hydrazine moiety, on the other hand, adds versatility by enabling amide or urea-like interactions, which are highly desirable in drug design.
Recent studies have highlighted the potential of 5-Pyrimidinecarbonitrile,4-hydrazinyl- as a scaffold for the development of anticancer and anti-inflammatory agents. Its ability to undergo various reactions, such as nucleophilic substitutions and condensations, makes it an ideal candidate for constructing complex heterocyclic compounds with tailored biological activities.
In the realm of pharmaceutical chemistry, this compound has been explored for its role in targeted drug delivery systems. The hydrazine group can be functionalized to form biodegradable linkers, enabling controlled release of therapeutic agents. This attribute positions it as a promising component in the development of nanomedicines and smart drugs.
Furthermore, advancements in computational chemistry have allowed researchers to predict the binding affinities of this compound with various pharmacological targets. Molecular docking studies have revealed that 5-Pyrimidinecarbonitrile,4-hydrazinyl- exhibits significant affinity for kinase and receptor molecules, suggesting its potential as a lead compound in the discovery of enzyme inhibitors.
The synthesis of 5-Pyrimidinecarbonitrile,4-hydrazinyl- is straightforward and can be achieved through a series of nucleophilic substitutions starting from cyanopyridines. Its scalability makes it suitable for both laboratory and industrial applications. Recent research has also explored the use of microwave-assisted chemistry to optimize its synthesis, reducing reaction times and enhancing yields.
In conclusion, 5-Pyrimidinecarbonitrile,4-hydrazinyl- stands out as a versatile and valuable compound in the field of biomedical sciences. Its unique structural features, combined with its potential for functionalization, make it an attractive candidate for drug development, chemical synthesis, and biotechnology applications. As research in these areas continues to evolve, this compound is poised to play a significant role in addressing unmet medical needs.
16357-75-8 (5-Pyrimidinecarbonitrile,4-hydrazinyl-) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)